Park JH - Search Results

1

Response to imatinib in KIT- and PDGFRA-wild type gastrointestinal stromal associated with neurofibromatosis type 1.

Lee JL, Kim JY, Ryu MH, Kang HJ, Chang HM, Kim TW, Lee H, Park JH, Kim HC, Kim JS, Kang YK. Lee JL, et al. Among authors: park jh. Dig Dis Sci. 2006 Jun;51(6):1043-6. doi: 10.1007/s10620-006-8003-1. Dig Dis Sci. 2006. PMID: 16865565 No abstract available.

2

Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea.

Yoo C, Ryu MH, Huh J, Park JH, Kang HJ, Ahn HS, Lee Y, Kim MJ, Lee H, Kim TW, Chang HM, Lee JL, Kang YK. Yoo C, et al. Among authors: park jh. Am J Hematol. 2007 Sep;82(9):821-3. doi: 10.1002/ajh.20962. Am J Hematol. 2007. PMID: 17570512 Free article.

3

Gastroprotective action of Cochinchina momordica seed extract is mediated by activation of CGRP and inhibition of cPLA(2)/5-LOX pathway.

Kang JM, Kim N, Kim B, Kim JH, Lee BY, Park JH, Lee MK, Lee HS, Jang IJ, Kim JS, Jung HC, Song IS. Kang JM, et al. Among authors: park jh. Dig Dis Sci. 2009 Dec;54(12):2549-60. doi: 10.1007/s10620-008-0671-6. Dig Dis Sci. 2009. PMID: 19130224

4

The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea.

Kim N, Cho SI, Lee HS, Park JH, Kim JH, Kim JS, Jung HC, Song IS. Kim N, et al. Among authors: park jh. Dig Dis Sci. 2010 Jan;55(1):101-10. doi: 10.1007/s10620-008-0688-x. Epub 2009 Jan 29. Dig Dis Sci. 2010. PMID: 19184427

5

Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.

Park JH, Lee JL. Park JH, et al. Cancer Chemother Pharmacol. 2015 Feb;75(2):247-54. doi: 10.1007/s00280-014-2640-4. Epub 2014 Nov 27. Cancer Chemother Pharmacol. 2015. PMID: 25428517

6

Risk factors for selection of patients at high risk of recurrence or death after complete surgical resection in stage I gastric cancer.

Park JH, Ryu MH, Kim HJ, Ryoo BY, Yoo C, Park I, Park YS, Oh ST, Yook JH, Kim BS, Kang YK. Park JH, et al. Among authors: park ys, park i. Gastric Cancer. 2016 Jan;19(1):226-33. doi: 10.1007/s10120-015-0464-5. Epub 2015 Jan 23. Gastric Cancer. 2016. PMID: 25614467

7

Successful control of heavily pretreated metastatic gastric cancer with the mTOR inhibitor everolimus (RAD001) in a patient with PIK3CA mutation and pS6 overexpression.

Park JH, Ryu MH, Park YS, Park SR, Na YS, Rhoo BY, Kang YK. Park JH, et al. Among authors: park sr, park ys. BMC Cancer. 2015 Mar 13;15:119. doi: 10.1186/s12885-015-1139-7. BMC Cancer. 2015. PMID: 25886409 Free PMC article.

8

How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.

Park JH, Lee JS, Koo H, Kim JE, Ahn JH, Ryu MH, Park SR, Yoon SK, Lee JC, Hong YS, Kim SY, Kim KP, Yoo CH, Hong JY, Lee JL, Jung KH, Rhyoo BY, Kim TW. Park JH, et al. Among authors: park sr. J Cancer Educ. 2020 Jun;35(3):545-556. doi: 10.1007/s13187-019-01494-6. J Cancer Educ. 2020. PMID: 30820925

9

Comparison of the Data of a Next-Generation Sequencing Panel from K-MASTER Project with That of Orthogonal Methods for Detecting Targetable Genetic Alterations.

Choi YJ, Choi JY, Kim JW, Lim AR, Lee Y, Chang WJ, Lee S, Sung JS, Chung HJ, Lee JW, Kang EJ, Kim JS, Lim T, Kim HS, Kim YJ, Ahn MS, Kim YS, Park JH, Lim S, Cho SS, Cho JH, Shin SW, Park KH, Kim YH. Choi YJ, et al. Among authors: park jh, park kh. Cancer Res Treat. 2022 Jan;54(1):30-39. doi: 10.4143/crt.2021.218. Epub 2021 May 20. Cancer Res Treat. 2022. PMID: 34015890 Free PMC article.

10

Treatment Patterns and Prognosis of Palliative Chemotherapy Combined With Targeting Agents in Patients With Unresectable Metastatic Colorectal Cancer: CHOICE, A Multicenter Longitudinal Observational Study.

Kim JH, Cha Y, Shin SJ, Park YS, Kang JH, Kim C, Lim SH, Kang MJ, Kim JG, Hwang IG, Choi JK, Shin SH, Kang SY, Lee SC, Lim ST, Kim JS, Jeung HC, Kang MH, Choi IS, Ryu HW, Lee KH, Lee MH, Lee JY, Park JH, Jeon SY, Lee N, Park CY, Kim YH. Kim JH, et al. Among authors: park jh, park ys, park cy. Anticancer Res. 2024 Jan;44(1):347-359. doi: 10.21873/anticanres.16818. Anticancer Res. 2024. PMID: 38160001

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,389 results

Search Page

Filters